These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3936148)

  • 1. [Special aspects of ovarian stimulation and in vitro fertilization].
    Lejeune B; Camus M; Vekemans M; Deschacht J; d'Oultremont G; Leroy F
    Rev Med Brux; 1985 Nov; 6(9):605-9. PubMed ID: 3936148
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of commercially available radioimmunoassays for the determination of luteinizing hormone in serum and urine. Application for the detection of endogenous rise of luteinizing hormone in a in vitro fertilization program.
    Liu Y; Naaktgeboren N; Heip J; Devroey P; Temmerman M; Verhoeven N; Van Steirteghem AC
    Ann Biol Clin (Paris); 1984; 42(6):419-25. PubMed ID: 6442546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian stimulation with clomiphene and/or human menopausal gonadotropin (HMG) for in vitro fertilization (IVF) and embryo transfer (ET).
    Kemeter P; Feichtinger W
    Experientia; 1985 Dec; 41(12):1502-7. PubMed ID: 3935476
    [No Abstract]   [Full Text] [Related]  

  • 4. Ovarian hyperstimulation for successful in vitro fertilization and embryo transfer.
    Gronow MJ
    Acta Obstet Gynecol Scand Suppl; 1985; 131():1-80. PubMed ID: 3925706
    [No Abstract]   [Full Text] [Related]  

  • 5. Ultrasound and the preovulatory human follicle.
    Bomsel-Helmreich O
    Oxf Rev Reprod Biol; 1985; 7():1-72. PubMed ID: 3936003
    [No Abstract]   [Full Text] [Related]  

  • 6. Enlargement of hydrosalpinges during ovarian stimulation protocols for in vitro fertilization and embryo replacement.
    Hill GA; Herbert CM; Fleischer AC; Webster BW; Maxson WS; Wentz AC
    Fertil Steril; 1986 Jun; 45(6):883-5. PubMed ID: 3086136
    [No Abstract]   [Full Text] [Related]  

  • 7. A study of factors affecting the success of human fertilization in vitro. I. Influence of ovarian stimulation upon the number and condition of oocytes collected.
    Testart J; Frydman R; De Mouzon J; Lassalle B; Belaisch JC
    Biol Reprod; 1983 Mar; 28(2):415-24. PubMed ID: 6220748
    [No Abstract]   [Full Text] [Related]  

  • 8. Ovarian stimulation regimens in an in vitro fertilization program: a comparative analysis.
    Bayly CM; McBain JC; Clarke GA; Gronow MJ; Johnston WI; Martin MJ; Speirs AL
    Ann N Y Acad Sci; 1985; 442():123-7. PubMed ID: 3925832
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of multiple ovarian follicles for in vitro fertilization in a patient with an undiagnosed ectopic pregnancy.
    Serafini P; Yee B; Vargyas J; Marrs RP
    Fertil Steril; 1985 Apr; 43(4):656-8. PubMed ID: 3157607
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of the daily concentration of estradiol on the morphological characteristics of the cumulus-corona-oocyte complex obtained in in vitro fertilization programs].
    Zegers F; Fernández E; Hess R; Roblero L; Ortiz ME; Altieri E; Guadarrama A
    Rev Chil Obstet Ginecol; 1984; 49(5):330-6. PubMed ID: 6443231
    [No Abstract]   [Full Text] [Related]  

  • 11. Monitoring of ovarian response to stimulation in in-vitro fertilization cycles.
    Kerin JF; Warnes GM
    Clin Obstet Gynecol; 1986 Mar; 29(1):158-70. PubMed ID: 3082553
    [No Abstract]   [Full Text] [Related]  

  • 12. Follicular recruitment is reduced in minimal stimulation for controlled ovarian hyperstimulation using purified human menopausal gonadotropin compared with follicle-stimulating hormone.
    Park JK; Clark R; Session DR
    Fertil Steril; 2009 Apr; 91(4 Suppl):1434-6. PubMed ID: 18701097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent data concerning the use of ovulation inductors during in vitro fertilization programs.
    Frydman R
    Acta Eur Fertil; 1985; 16(1):5-11. PubMed ID: 3925678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regulation principles of female gonadal function. Experimental observations and clinical significance].
    Czygan PJ
    Fortschr Geburtshilfe Gynakol; 1974; 52():121-98. PubMed ID: 4618236
    [No Abstract]   [Full Text] [Related]  

  • 15. Refractory postpartum ovarian response to gonadal stimulation in nonlactating women.
    Zarate A; Canales ES; Soria J; Leon C; Garrido J; Fonseca E
    Obstet Gynecol; 1974 Dec; 44(6):819-22. PubMed ID: 4437819
    [No Abstract]   [Full Text] [Related]  

  • 16. The importance of the FSH/LH ratio in ovarian stimulation therapy regime for in vitro fertilization.
    Bhat AM; Feichtinger W; Kemeter P
    Acta Eur Fertil; 1984; 15(6):449-53. PubMed ID: 6443053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The response to ovarian hyperstimulation and in-vitro fertilization in women older than 35 years.
    Segal S; Casper RF
    Hum Reprod; 1990 Apr; 5(3):255-7. PubMed ID: 2112553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of follicle-stimulating hormone test to predict poor response in in vitro fertilization.
    Iwase A; Ando H; Kuno K; Mizutani S
    Obstet Gynecol; 2005 Mar; 105(3):645-52. PubMed ID: 15738039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of purified gonadotrophins for ovarian stimulation in IVF.
    Jones GS
    Clin Obstet Gynaecol; 1985 Dec; 12(4):775-84. PubMed ID: 3938687
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of different methods of ovarian stimulation for human in vitro fertilization and embryo replacement.
    Vargyas JM; Morente C; Shangold G; Marrs RP
    Fertil Steril; 1984 Nov; 42(5):745-9. PubMed ID: 6436069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.